Drug Shortage Report for FOLIC ACID INJECTION, USP

Last updated on 2025-10-15 History
Report ID 268583
Drug Identification Number 02139480
Brand name FOLIC ACID INJECTION, USP
Common or Proper name FOLIC ACID INJECTION, USP
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) FOLIC ACID
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 10 mL
ATC code B03BB
ATC description VITAMIN B12 AND FOLIC ACID
Reason for shortage Demand increase for the drug.
Anticipated start date 2025-11-01
Actual start date 2025-10-14
Estimated end date 2026-01-15
Actual end date
Shortage status Actual shortage
Updated date 2025-10-15
Company comments Fresenius Kabi Canada regrets to advise that due to a further increase in demand, we have encountered a supply interruption on our Folic Acid Injection, USP 5 mg/mL, 10 mL Vial earlier than expected. Inventory has now been depleted effective October 14, 2025. We estimate availability of stock by January 15, 2026.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2025-10-15 French Compare
v4 2025-10-15 English Compare
v3 2025-10-15 English Compare
v2 2025-10-03 French Compare
v1 2025-10-03 English Compare

Showing 1 to 5 of 5